乳酸对心脏重症监护室心脏骤停与休克患者的预后价值
该回顾性观察分析纳入2007至2018年Mayo Clinic心脏重症监护室3042例入院时测过乳酸的患者,其中26%有心脏骤停、39%有休克,住院死亡率23%。入院乳酸中位数1.8 mmol/L,住院死亡率随入院乳酸升高而逐步上升,有无心脏骤停或休克者均如此。多因素校正临床特征、治疗与病情严重程度后,乳酸每升高1 mmol/L与住院死亡率升高独立相关(校正OR 1.13,95%CI 1.06-1.20,P<0.001)。作者认为乳酸的预后价值独立于现有ICU预后评分,且取决于入院诊断。
要点
- 心脏重症监护室患者入院乳酸每升高1 mmol/L,住院死亡率独立升高(校正OR 1.13,95%CI 1.06-1.20,P<0.001)。
- 住院死亡率随入院乳酸升高逐步上升,在有无心脏骤停或休克的患者中均可见此趋势。
- 队列住院死亡率23%,入院乳酸中位数1.8 mmol/L(IQR 1.1-3.0),APACHE-IV预测死亡率中位数24%(IQR 11-51%)。
- 乳酸的预后价值独立于现有ICU预后评分,且取决于入院诊断。
适用人群与场景
- 2007至2018年Mayo Clinic心脏重症监护室入院且入院时测过乳酸的患者,包括有和无心脏骤停或休克者;队列中26%有心脏骤停、39%有休克。
研究设计与关键结果
- 回顾性观察分析,纳入3042例心脏重症监护室患者,中位年龄70岁(IQR 60-80),41%为女性,26%有心脏骤停,39%有休克。
- 入院乳酸中位数1.8 mmol/L(IQR 1.1-3.0),APACHE-IV预测死亡率中位数24%(IQR 11-51%),住院死亡率23%。
- 住院死亡率随入院乳酸升高逐步上升,在有无心脏骤停或休克的患者中均如此。
- 多因素校正临床特征、治疗与病情严重程度后,乳酸每升高1 mmol/L与住院死亡率升高独立相关(校正OR 1.13,95%CI 1.06-1.20,P<0.001)。
证据类型、等级与局限
- 证据类型:回顾性观察分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为乳酸的预后价值独立于现有ICU预后评分且取决于入院诊断,可能有助于指导心脏重症监护室患者的临床诊疗。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Lactate is a prognostic marker in critically ill patients, although currently available illness severity scores do not include lactate as a predictive parameter. We sought to describe the association between lactate and hospital mortality in patients admitted to the cardiac intensive care unit (CICU) with cardiac arrest (CA) and shock.
METHODS: Retrospective observational analysis of Mayo Clinic CICU patients admitted from 2007 to 2018 with measured lactate on admission, including patients with and without CA or shock. We examined hospital mortality as a function of admission lactate in patients. Multivariable logistic regression was used to determine predictors of hospital mortality.
RESULTS: We included 3,042 patients with a median age of 70 years (IQR 60-80), including 41% females, 26% with CA, and 39% with shock. The median APACHE-IV predicted mortality was 24% (IQR 11-51%), and the median admission lactate was 1.8 mmol/L (IQR 1.1-3.0). Hospital mortality occurred in 23% of patients and rose progressively with higher admission lactate, including in patients with and without CA or shock. After multivariable adjustment for clinical characteristics, therapies, and illness severity, a higher lactate remained associated with increased hospital mortality (adjusted OR 1.13 per mmol/L, 95% CI 1.06-1.20, P < 0.001).
CONCLUSIONS: Admission lactate levels are strongly associated with increased hospital mortality among CICU patients, including those with and without CA or shock. The prognostic value of lactate levels is independent of established ICU prognostic scores and dependent on admission diagnosis, which may help inform clinicians caring for CICU patients.
参考来源
- Burstein B, Vallabhajosyula S, Ternus B, et al. The Prognostic Value of Lactate in Cardiac Intensive Care Unit Patients With Cardiac Arrest and Shock. Shock. 2021. PMID: 32496423. doi:10.1097/SHK.0000000000001582
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。